Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).
Feature | Antiplatelet and Anticoagulation Therapies

December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of ...

Home December 27, 2019
Home
Peter Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.
Feature | EP Lab | J. Peter Weiss, M.D., MSc

Robotic technology, which helps carry out repetitive tasks efficiently and precisely, has been gaining ground in society ...

Home December 23, 2019
Home
News | AHA

November 22, 2019 — Artificial intelligence can examine electrocardiogram (ECG) test results, a common medical test, to ...

Home November 22, 2019
Home
News | Cardiovascular Surgery

October 23, 2019 — Proactive administration of amiodarone to patients recovering from a common heart surgery shows ...

Home October 23, 2019
Home
News | Atrial Fibrillation

October 22, 2019 —  Drinking small amounts of alcohol frequently is linked with a higher likelihood of atrial ...

Home October 22, 2019
Home
News | Atrial Fibrillation

October 22, 2019 — Atrial fibrillation is the most common heart arrhythmia in humans. This condition increases the risk ...

Home October 22, 2019
Home
News | Wearables

October 17, 2019 — The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New ...

Home October 17, 2019
Home
News | EP Mapping and Imaging Systems

October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...

Home October 15, 2019
Home
The life of Afib patient Glynn Crawford was saved three days after being prescribed a Zoll LifeVest wearable defibrillator by his cardiologist Barbara Williams, M.D., at   University Hospitals Ahuja Medical CenterShe identified him as a high-risk for sudden cardiac arrest.
Feature | Sudden Cardiac Arrest

October 7, 2019 — Glynn Crawford was hospitalized at University Hospitals Ahuja Medical Center in late June/early July ...

Home October 07, 2019
Home
News | Heart Failure

September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept. 30 ...

Home September 20, 2019
Home
InfoBionic’s MoMe Kardia remote ECG monitor is an example of the newer generation devices that are replacing traditional Holter monitors. It has a single button for patients to create an alert when they are experiencing arrhythmia symptoms.
Feature | ECG Wireless Remote Access | Stuart Long and Colin Movsowitz, M.D.
Until recently, cardiologists trying to diagnose and treat arrhythmias have had to deal with technological limitations ...
Home August 30, 2019
Home
Blog | Wearables

 


Atrial fibrillation, or Afib, kills about 130,000 people worldwide every year. It also affects 3 to 6 million ...

Home August 29, 2019
Home
News | EP Mapping and Imaging Systems

August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper ...

Home August 19, 2019
Home
Videos | EP Lab

Mark Ibrahim, M.D., FACC, assistant professor of medicine and radiology, associate program director, advanced cardiac ...

Home July 26, 2019
Home
Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.
Feature | Atrial Fibrillation

July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm. It is treated either with medications or ...

Home July 24, 2019
Home
Subscribe Now